Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
XIIDRA (Shire Australia Pty Ltd)
Product name
XIIDRA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
216 working days (255)
Active ingredients
lifitegrast
Registration type
NCE/NBE
Indication
XIIDRA (eye drops) is indicated for the treatment of moderate to severe dry eye disease in adults for whom prior use of artificial tears has not been sufficient.